
Spero Therapeutics: An Update on Their Presentation at TD Cowen’s 45th Annual Health Care Conference
Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference Cambridge, MA, USA – Spero Therapeutics, a pioneering clinical-stage biopharmaceutical company focused on the discovery and development of innovative treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, has announced that Esther Rajavelu, Interim President and CEO, will present at the TD…